Histone Deacetylase Inhibitor Improves Aggressive Lymphoma Treatment Outcomes
A particularly aggressive form of blood cancer may finally have a more effective treatment approach. MYC/BCL2 double-expressor diffuse large B-cell lymphoma…
Found 1715 results for "cancer"
A particularly aggressive form of blood cancer may finally have a more effective treatment approach. MYC/BCL2 double-expressor diffuse large B-cell lymphoma…
Solid tumor treatment has reached a potential inflection point as researchers demonstrate that removing a single gene can transform engineered immune cells…
Quality certification programs for cancer care face persistent scrutiny over whether bureaucratic credentialing translates into measurable patient benefits…
Advanced breast cancer continues to claim more lives despite decades of awareness campaigns and screening improvements, challenging assumptions about early…
The concept of making cancer cells die in ways that alert the immune system represents a paradigm shift from simply killing tumors to recruiting the body's…
Precision cell elimination based on genetic profiles has long been a holy grail in cancer therapy and biotechnology. Until now, most CRISPR systems designed…
Precision oncology continues refining treatment selection for patients with specific genetic mutations, particularly those with rare but actionable targets…
Senescent cells in melanoma tumors create a paradoxical double-edged sword: they suppress tumor growth through cell cycle arrest and immune activation, yet…
Cancer metastasis has long been viewed as a chaotic process, but emerging evidence reveals that blood vessels create organized microenvironments that…
Precision medicine for gastric cancer has taken a significant step forward with the identification of five distinct tumor microenvironments that determine…
Two decades of tracking nearly 4,000 breast cancer patients reveals a fundamental trade-off in radiation therapy that challenges current treatment paradigms…
The transition from localized melanoma to metastatic disease represents one of oncology's most lethal progressions, yet the molecular switches governing this…
The evolution of cellular cancer immunotherapy represents a fundamental shift in how medicine harnesses the body's immune system to eliminate malignancies…
The ability to predict which prostate cancer patients will benefit most from hormone-blocking therapy could fundamentally change treatment planning for men…
Understanding how cancer cells accumulate DNA damage could revolutionize personalized treatment strategies, particularly for breast cancer patients where…
A paradigm shift in early-stage breast cancer treatment could spare thousands of women from surgery while maintaining excellent outcomes. This approach…
Despite aggressive treatment protocols, nearly one-third of high-risk bladder cancers return within two years, creating an urgent clinical challenge as global…
Cancer's ability to hijack cellular communication represents one of the most challenging aspects of treatment resistance. New evidence reveals how solute…
Understanding how cancer cells maintain their aggressive growth signals could unlock new therapeutic targets for one of the deadliest malignancies. Colorectal…
Understanding how cancer cells evade programmed death could revolutionize treatment approaches for one of the most lethal gynecologic malignancies. This…